Vantage logo

Why not bapineuzumab?

Like Aduhelm this long-discontinued amyloid beta MAb reduced brain beta amyloid; so have several other industry projects.

Vantage logo

Recycling pays off for Mereo

The company has spent five years buying in discontinued projects, and at last has managed to sell one of these on at a nice profit.

Vantage logo

Curevac rides the Covid wave

Curevac’s market cap has ballooned almost fivefold since floating, sending the mRNA company into the record books.